Results 141 to 150 of about 147,527 (217)

Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. [PDF]

open access: yesRev Peru Med Exp Salud Publica, 2023
Rodríguez-Tanta LY   +5 more
europepmc   +1 more source

Causas múltiples de muerte

open access: yesRevista Cubana de Higiene y Epidemiología
Se presenta un estudio de causas múltiples de muerte, en la población cubana de 1 año y más de edad. La información se obtuvo de una muestra de 2 036 defunciones ocurridas durante 4 meses consecutivos en 22 municipios del país.
Norma Eneida Ríos Massabot   +2 more
doaj  

El contribuyente y la Administración Electrónica Tributaria

open access: yes, 2016
ABSTRACT: The constant changes in the technologies of the information and the communications stimulate the Public Administrations to modernise, computerising great part of the accomplishment of its steps and procedures, being more effective and productive this way and offering a major agility and comfort in the presentation of these services to the ...
openaire   +1 more source

[Perioperative morbidity and mortality of cardiac surgeries at the Instituto Nacional Cardiovascular, Lima, Peru, during the year 2023]. [PDF]

open access: yesArch Peru Cardiol Cir Cardiovasc
Silva-Tejada H   +4 more
europepmc   +1 more source

Root cause analysis of safety incidents in antineoplastic use in children. [PDF]

open access: yesRev Bras Enferm
Barreto EDG   +5 more
europepmc   +1 more source

[Spectrum of opportunistic fungal lung co-infections in COVID-19: What the radiologist needs to know]. [PDF]

open access: yesRadiologia, 2022
Nair AV   +7 more
europepmc   +1 more source

Analysis of Uncertainty and Sensitivity in Tailings Dam Breach-Runout Numerical Modelling. [PDF]

open access: yesMine Water Environ
Ghahramani N   +6 more
europepmc   +1 more source

Tools for the investigation of adverse events: scoping review. [PDF]

open access: yesRev Esc Enferm USP, 2022
Mello LRG   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy